Skip to content

Establishment of Individualized Precision Medical Drug Screening and Evaluation System for Gastric Cancer

Establishment of Individualized Precision Medical Drug Screening and Evaluation System for Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021296
Enrollment
Unknown
Registered
2019-02-12
Start date
2013-09-01
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Sponsors

Digestive Hospital of Xijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Histopathological examination confirmed the diagnosis of gastric cancer, and needs systematic anticancer therapy; 2. Clinical examination with no other tumor 3. Can obtain fresh tumor tissues or pleural effusion or ascites samples by surgical resection or biopsy; 4. With tumor foci meeting the RECIST 1.1 standard; Can evaluate the efficacy by CT/MRI; 5. KPS scores=60; expected survival = 3 months; 6. Voluntary to participate and sign informed consent document; Compliance is good, can suffer actively treatment and cooperate with follow-ups.

Exclusion criteria

Exclusion criteria: 1. The occurrence of unplanned reoperation postoperative ; 2. Found other tumors during the treatment process which interferes the experimental study; 3. KPS score <60 points or blood biochemical tests suggest that patients are not suitable for continuing chemotherapy or chemotherapy needs to be delayed; 4. Cant or refused to collect tumor samples, including tumor specimens or circulating tumor cells; 5. Do not cooperate with the relevant treatment program or follow-up program.

Design outcomes

Primary

MeasureTime frame
Efficacy study in Patient Derived Xenograft Model;mini-PDX drug sensitivity;

Countries

China

Contacts

Public ContactZhao Qingchuan

Digestive Hospital of Xijing Hospital

hlhyhj@126.com+86 13809153899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026